on 12 Nov 2024
Last Applicant/ Owned by
306 W Franklin St., Suite F
Chapel Hill
NC
27516
Serial Number
97525470 filed on 29th Jul 2022
Registration Number
7566110 registered on 12th Nov 2024
Correspondent Address
Dustin R. Marlan TMCP-UNC
Dustin R. Marlan TMCP-UNC UNC SCHOOL OF LAW
CLINICAL PROGRAMS CB#3333
CHAPEL HILL, NC 27514
United States
Filing Basis
1. intent to use
2. use application currently
Disclaimer
NO DATA
Medical research; Scientific research; Science and Technology Services, namely, technical consultation and scientific research in the field of cannabinoid-based medicines and pharmaceuticals; Development of precision cannabinoid therapeutics through digital therapeutics, medical research, scientific research, and expert consultation; Biological research; Compiling data for research purposes in the Read More
Patient and family health care coordination services for use in case management, namely, providing health care advisory and management services for coordinating legal, medical, physical, social, personal care and psychological services
28th Feb 2023
23rd May 2024
Medical services; Medical clinical services; Health counseling; Health care and wellness services, namely, medication tracking, patient education, and patient-centric health coaching and counseling; Pharmaceutical advice; Telemedicine services; Medical services, namely, providing medical advice in the nature of medicinal cannabidiol (CBD) recommendations and other product recommendations for medical treatment purposes and related ongoing medical care to patients; health care services, namely, providing remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; Providing medical information in the field of therapeutic botanical substances; Providing health information in the field of cannabidiols, and regarding indications and effects of particular cannabis strains; Medical consultation services, namely, assessing patients for eligibility requirements for the use of cannabidiols; Providing medical testing of fitness for diagnostic purposes and medical consultations to individuals to help them make health, wellness, and nutritional changes to improve health
28th Feb 2023
23rd May 2024
Medical research; Scientific research; Science and Technology Services, namely, technical consultation and scientific research in the field of cannabinoid-based medicines and pharmaceuticals; Development of precision cannabinoid therapeutics through digital therapeutics, medical research, scientific research, and expert consultation; Biological research; Compiling data for research purposes in the field of medical science and medical consultancy; Research and development in the field of prescription digital therapeutics targeting serious medical conditions; Research and development of technology in the field of identifying drugs as recommended replacements for pain treatments, sleep treatments, and epilepsy treatments; Research and development of technology in the field of the prescription of therapeutic exercise programs; Research in the field of pharmaceutical studies; Platform as a service (PAAS) featuring computer software platforms for the development, deployment, and operation of patient-directed software for tracking prescription use and personal medical data in the field of Digital Therapeutics and treatment support; Software as a service (SaaS) and Platform as a service (PAAS) for targeting, monitoring, intervening, and managing human health conditions, behaviors, and disease, and treatments related thereto; Providing temporary use of online non-downloadable computer software for counseling and providing digital therapeutics that utilize digital and online health technologies to treat and manage medical or psychological conditions; Software as a service (SaaS) services featuring software for creating, accessing and editing electronic health records; Providing temporary use of non-downloadable computer application software, namely, software for integrating risk evaluation data, mitigation strategies, and digital therapeutics data into electronic health records; Providing interactive web-based communication platform as a service featuring computer software platforms for medical and biological data sharing, namely, disease, treatment, trial, outcome and molecular diagnostic test results for decision support; Providing an interactive web site featuring technology that enables users to enter, access, track, monitor and generate health and medical information and reports; Software as a service (SAAS) services featuring software for integrating and analyzing patient health data for predictive analysis of health risks and health events; Software as a service (SAAS) featuring software in the fields of healthcare, medicine and wellness for the purpose of providing an integrated health information management system using machine learning and artificial intelligence, namely, software for providing patients and health care providers access to patient information and data, and for providing patients access to personalized information relevant to patient health and wellbeing; Providing temporary use of online non- downloadable interactive web-based software application featuring technology that enables care providers and users to enter, access, and generate health and medical information and reports; Software as a service (SaaS) services featuring non-downloadable software for remote monitoring of patients, the collection and transfer of healthcare data, facilitating communications and engagement among and between healthcare professionals, patients, vendors and suppliers of healthcare products and pharmaceuticals, and to provide healthcare counseling and social support services to patients; Providing a website featuring medical research information related to cannabidiols
28th Feb 2023
23rd May 2024
Downloadable computer software for providing counseling and digital therapeutics that utilize digital health technologies to treat and manage medical or psychological conditions; Downloadable computer application software, namely, software for processing electronic health records; Downloadable computer application software, namely, software for integrating risk evaluation information, mitigation strategies, and digital therapeutics into electronic health records; Downloadable software in the fields of healthcare, medicine and wellness for use in providing patient communication, care coordination and care management, chronic disease management, and engagement between health care providers and patients; Downloadable mobile application featuring technology that enables care providers and users to enter, access, and generate health and medical information and reports; Computer software, namely, downloadable software and mobile application software for remote monitoring of patients, the collection and transfer of healthcare data, facilitating communications and engagement among and between healthcare professionals, patients, vendors and suppliers of healthcare products and pharmaceuticals and to provide healthcare counseling and social support services to patients; Downloadable computer software, namely, downloadable software and mobile application software for connecting to, with and through smart devices and smart appliances, for the purposes of collecting data and health information for patient monitoring and communications purposes from and through such smart devices and smart appliances
23rd May 2024
23rd May 2024
No 97525470
No Service Mark
No 03094
No
No
No
No
No
No
No
No
Status Date | Action Taken |
---|---|
12th Nov 2024 | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
12th Nov 2024 | REGISTERED-PRINCIPAL REGISTER |
08th Oct 2024 | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
08th Oct 2024 | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
20th Aug 2024 | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
20th Aug 2024 | STATEMENT OF USE PROCESSING COMPLETE |
25th Jun 2024 | TEAS STATEMENT OF USE RECEIVED |
25th Jun 2024 | USE AMENDMENT FILED |
26th Dec 2023 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
30th Nov 2023 | TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS |